Introduction
Patients with severe depressive illness frequently manifest a Cushing-like syndrome with hypersecretion of cortisol, particularly in the late evening and early morning, associated with relative resistance to dexamethasone suppression (17) . To what extent these cortisol abnormalities relate to specific psychiatric disorders, to a subgroup of depressive illness, or to the presence of emotional arousal is uncertain. Although the response to a high dose of dexamethasone is of crucial importance in the differential diagnosis of Cushing's syndrome (11) we have found no reference in the literature to the use of a two-dose dexamethasone test in psychiatric patients.
This investigation was carried out with the following purpose:
• to examine the clinical and psychological correlates of dexamethasone suppression in hospitalized psychiatric patients,
• to confirm the report of some investigators (4) that abnormal dexamethasone suppression successfully discriminates depressed from non-depressed subjects and that the dexamethasone suppression test may be of value as a laboratory aid in the diagnosis of endogenous depression,
• to determine whether adrenocortical overactivity in psychiatric illness can be suppressed by a high dose of dexamethasone. ' Can. Psychiatr. Assoc. J. Vol. 22 (1977) Methodology Patient population -This consisted of 34 consecutive patients admitted to the acute psychiatric ward of a general hospital over a one year period. The criteria for selection were that the patient be sufficiently well to understand and cooperate with the tests and be managed without major tranquilizers, antidepressant medication or ECT, for at least two weeks. Because of its possible influence on steroid levels or dexamethasone suppression, patients with active physical disease were excluded from the study, as were women who were pregnant or on birth control pills. Criteria/or psychiatric diagnoses -The patients were classified into three main diagnostic groups: primary depression, mania, and schizophrenia, using the criteria of Feighner et al. (6) . Using an alternate classificatory system the patients with primary depression were then reclassified into "endogenous" and "other depressive" subgroups using the Catego classification (23) . The "endogenous" group combined the Class D depressive psychosis and Class R retarded depressions. The "other depressions" consisted of the Class N neurotic depressions and depressed patients with markedly unusual hysterical or antisocial personality trait disorder.
Psychological tests -
Within 48 hours of admission all the patients with primary depression were rated on the Max Hamilton Rating Scale for Depression (9) . Within the next five days other psychological measurements were made of anxiety and psychomotor retardation using, respectively, the Taylor Manifest Anxiety Scale (21) and the Digit Symbol Subtest of the Wechsler Adult Intelligence Scale (22) , appropriately adjusted for age. Endocrine protocol -During the first five days there was a washout period in which no drugs were allowed, with the exception of Chloral Hydrate for insomnia or chlordiazepoxide for sedation. This time interval also allowed for a settling-in period during the process of early hospitalization. On Day 6 and 7, blood samples Vol. 22, No.8 for plasma cortisol determinations were collected at 8:30 a.m. and 4:30 p.m. Dexamethasone was then administered by mouth at 6-hourly intervals at two-dose levels. Initially, a dose of 2 mg daily was given for 48 hours and on the morning of Day 10 a blood sample for cortisol was taken at 8:30 a.m. This was followed by the administration of a high dose dexamethasone regime consisting of 8 mg daily for a further 48 hours and on Day 12, blood samples for cortisol determinations were made at 8:30 a.m. and 4:30 p.m. Laboratory methods -The method used for the determination of plasma cortisol was that of Mattingly (13) , further modified by James and others (10) . This method measures 11hydroxycorticosteroids and trace amounts of corticosterone. The normal range for this laboratory was 10 to 28 micrograms percent. Definition of cortisol abnormalities -These were derived from the laboratory norms and from standard procedures then being used by the Department of Endocrinology. High cortisol levels were defined as equal to or in excess of 30 micrograms percent of cortisol on either baseline days prior to dexamethasone. Abnormal dex-amethasone suppression was defined as failure of the plasma cortisol to suppress below the low normal laboratory level, that is 10 micrograms percent, either on morning or afternoon blood samples, after the administration of dexamethasone. A loss of circadian rhythm was defined as a 4:30 p.m. cortisol level that was at least 75 percent as high as the morning 8:30 a.m. level on baseline days. Figure 1 shows that on the 2 mg dose regime all the patients suppressed normally with the exception of five patients with primary depression and two with acute schizophrenia. On the 8 mg dexamethasone regime, in the morning, three of these abnormal suppressors now suppressed normally but four of the patients with primary depression showed continuing nonsuppression. One other patient with primary depression had a paradoxical nonsuppression on 8 
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:.::-· .. · . ." ::. mg per day compared to a normal suppression on 2 mg a day. By late afternoon there was a further escape from suppression shown in total by eight (34%) of the patients with primary depression, by one of the patients with manic illness and by two (25%) with acute schizophrenia, only one of whom had been a nonsuppressor on 2 mg per day. Hence abnormal dexamethasone suppression is not pathognomonic of primary depression as it occurs also in mania and in acute schizophrenia.
Clinical and Cortisol Abnormalities in the Depressive Subgroups
As the primary purpose of this investigation was the evaluation of the dexamethasone suppression test in patients with primary depression, clinical, psychometric, and cortisol comparisons were made in the depressive subgroups. Reflecting their membership of the subclass as well as their clinical presentation, endogenous depressed patients were significantly older (p<.Ol), tended to have more psychomotor retardation (p< .10) and to have more weight loss (p< .10). The "other depressives" had more autonomic anxiety (p<.05), and all of the ten suicidal patients belonged to this subgroup (p<.02). The "other depressives" were more likely to be suicidal patients treated by psychotherapy alone (p<.IO) whereas proportionately more of the endogenous depressed patients were nonsuicidal and treated with physical therapies, such as, antidepressant drugs or ECT (p<.05). Figure 1 shows that the highest morning cortisol levels were found in patients with "other depression". Their mean p.m. level on two baseline days was also significantly higher (p<.Ol). However in these two depressive subgroups there was no significant difference in the number of patients with abnormal suppression on either a low or high dose of dexamethasone. That is, abnormal dexamethasone suppression did not discriminate the "endogenous" depressed from the "other depressed" subjects.
Comparison of Normal and Abnormal Dexamethasone Suppressors
These groups did not differ in mean age, sex composition, or relative numbers who were obese or who required medication with librium or Chloral Hydrate during this study. On the Max Hamilton Scale for Depression, the global severity of the illness did not separate suppressors from nonsuppressors. There were also no differences in depressive mood, guilt, psychomotor retardation, agitation, and psychic or autonomic anxiety. Nor were there differences in diurnal variation of symptoms, loss of weight, patterns of insomnia or physical symptoms, that is, on those subtest scores reflecting the diagnosis of endogenous depression. There were, however, two trends short of statistical significance, namely, for nonsuppressors to be suicidal on admission (p<. 20) and to be treated by psychotherapy alone (p< .20).
Abnormal dexamethasone suppression occurred significantly more often in patients with one or more high cortisol levels on baseline days (p<.Ol). A loss of circadian rhythm present in 11 of the 34 patients had no relationship with baseline cortisol levels, nor with abnormal dexamethasone suppression.
Discussion
Abnormalities in the hypothalamic pituitary axis as tested by the dexamethasone suppression test have been reported in patients with depressive illness (4, 20) but some largely negative findings have also been described (3, 8, 19) . Some of these discrepancies may have been attributable to infrequent measurement of plasma cortisol, as there is now evidence that cortisol secretion occurs in episodic bursts throughout the day. In the present study, if the criteria for abnormal suppression had been confined to morning cortisol determinations, only five of the eleven patients with abnormal suppression would have been detected, as six other patients showed early escape from suppression when their cortisol levels were measured at 4:30 p.m. Hence, by including afternoon plasma cortisol determinations, we have confirmed the observation of Carroll and others (4) that the dimension of time is an important variable in detecting more subtle abnormalities of the hypothalamic pituitary axis. Inother respects our findings are different from Carroll's in that on the dexamethasone suppression test there was a substantial overlap of individual differences in all patient groups and subgroups under investigation. We have therefore concluded that the dexamethasone suppression test would be of little value as a laboratory aid in the diagnosis of endogenous depression.
It is unlikely that the disparity between various studies can be explained by a difference in the methods of estimating plasma corticosteroids (1) . The laboratory which measured our plasma cortisol now uses a competitive protein binding method. Prior to this laboratory change, a comparison was made between the Mattingly fluorometric method and the CPB method of Murphy with the finding that the mean value for the fluorescent technique was slightly higher. An excellent correlation was observed between the two techniques when group comparisons were made on the mean values at different time intervals. t
Depression and Adrenocorticol Overactivity
The concept of "endogenous" and ,'neurotic" is unsatisfactory, and the authors believe in a continuum view of depressive illness. At one end of this spectrum was our subgroup of patients with endogenous depression, unmodified by personality abnormality or acute psychosocial stress. At the other end of the continuum were our "other depressives" , corresponding to those depressive subgroups identified in factor analytic studies as the complaining, the neurotic, the hostile and the character disorders. In this investigation the highest cortisol levels both pre and post-dexamethasone were found in our "other depressives". This may have been related to a factor of emotional arousal as these elevated cortisol levels were found in those patients in acute crisis situations who were admitted as suicidal emergencies. Although this study controlled the medication given to the patients, this control could not extend to the ward milieu. All patients, and especially those in crisis situations, were the most likely to receive intensive group and individual psychotherapy. Their reactions tPersonal communication, F. Y. Leung.
were often brittle and angry. Useful additions to the study would have been objective daily ratings scales of behaviour and patient self-assessments of perceived threats or anxiety on the days of cortisol determination. Sachar and his colleagues have reported increased cortisol secretions when patients in psychotherapy were confronted with the losses responsible for their depression (15) . Elevations of steroid levels over an extended period have also been described in patients with a high suicidal potential (2) . Mason has extensively investigated the sensitivity of the pituitary adrenocortical system to psychological influences and has demonstrated enduring individual differences in steroid production -characterized by high, middle or low steroid levels -in response to stress, differences which he attributes to personality characteristics (12) . It has also been suggested that the hypersecretion of cortisol in certain depressive illnesses is not simply a stress response as usually envisaged but is rather a reflection of apparent limbic system dysfunction (16) . Patients with these profiles combining both psychological and physiological overreactivity to their environment might be expected to be overrepresented in psychiatric patients admitted through an emergency department, as was true of our suicidal"other depressives" .
Diencephalic Cushing's Syndrome
There is now impressive evidence that in some patients with depressive illness there may be a primary neuroendocrine disturbance (5, 18) . This can present biochemically as a Cushing's syndrome -probably of diencephalic or limbic origin -with elevated cortisol levels which may occur at midnight and during sleep, with loss of circadian rhythm and with abnormal dexamethasone suppression. A refinement to our study was the use of a two-dose dexamethasone regime which has shown that in some patients with this diencephalic Cushing's syndrome there is continued nonsuppression on exposure to a high dose of dexamethasone. Similar nonsuppression to a high dose of dexamethasone is found in patients with ectopic ACTH secretion and in patients with autonomous adrenal tumors (14) . Because belated recognition of adrenocorticotropic hormone-producing tumors has been described in some patients who have had an adrenalectomy for pituitary dependent Cushing's disease (7) , caution is necessary in the interpretation of partial suppression or persistent nonsuppression in psychiatric patients. As patients with Cushing's syndrome of uncertain etiology may be referred from endocrinologists for a psychiatric opinion, there is a clinical need to establish with some certainty the psychological correlates of this abnormality.
Summary
After exposure to a low and high dose dexamethasone regime, 11 of 34 acute psychiatric inpatients demonstrated abnormal dexamethasone suppression characterized by morning and/or mid-afternoon escape from suppression. This abnormality of suppression was found in primary depression, in mania, and in acute schizophrenia. In primary depression, the presence of abnormal dexamethasone suppression failed to discriminate "endogenous" depressed from "other depressed" subjects.
Because nonsuppression to a high dose of dexamethasone is also found in patients with ectopic ACTH secretion and in patients with autonomous adrenal tumors, caution is necessary in the interpretation of nonsuppression which persists after recovery from psychiatric illness. As patients with Cushing's syndrome of uncertain etiology may be referred to a psychiatrist for a diagnostic evaluation, the psychological correlates of abnormal dexamethasone suppression need to be established with greater certainty.
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